mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.73 |
0.005 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.006 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.006 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.006 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.006 |